More than 1.7million people aged 66 and over are currently receiving the payment, but many more could qualify. Research by Policy in Practice suggests that up to 1.1million pensioners were not ...

After struggling during seasons when MS took center stage, columnist Ahna Crum is enjoying the quieter days where it's only ...

Although a growing body of evidence suggests a positive impact of GLP-1 receptor agonists in treating MS, questions of health ...